Synthesis and 1H NMR Titration Study of 7-Deoxycholic Amide or Cholane Ionophores 193
12.3, 11.5; IR (CH2Cl2) νmax 3450, 2926, 2860, 1742,
[[[[(diethylamino)thioxo - methyl] thio]-acetyl]oxy]-
5β-cholane (11, 220 mg, 0.36 mmol) was dissolved
in dichloromethane (10 mL), slowly added to the re-
action mixture at 0◦C and stirred for 48 h at room
temperature. The reaction mixture was diluted with
CH2Cl2 (100 mL) and was washed with saturated
NaHCO3(aq) (1 × 100 mL), washed with water (1
× 100 mL), dried over MgSO4, and evaporated in
vacuo. The crude product was purified by silica gel
chromatography with ethyl acetate as an eluent to
yield 13a and ethyl acetate–hexane (6:4) as an elu-
ent to yield 13b and 13c as a waxy solid.
1724, 1636, 1463, 1418, 1271, 1203, 1143 cm−1; MS
(FAB) m/e 1018 (M+), 581 (M+-C40H71NO).
3α-[[[[4-(Diisobutylamino)-1,4-dioxobutyl]ami-
no]acetyl]oxy]-12α - [[[[(diethylamino)thioxomethyl]
thio] - acetyl]oxy] - N,N - dioctyl-5β-cholan-24-amide
(12b). Waxy solid; TLC (silica gel, 15%
acetone/CH2Cl2) Rf 0.52; 1H NMR (400 MHz,
CDCl3) δ 6.67 (t, J = 5.0 Hz, 1H), 5.13 (br s, 1H,
12β-H), 4.80–4.72 (m, 1H, 3β-H), 4.38 (d, J = 16.5
Hz, 1H), 4.22 (d, J = 16.5 Hz, 1H), 4.04–3.98 (m,
4H), 3.84–3.78 (m, 2H), 3.33–3.10 (m, 8H), 2.70 (t,J
= 6.3 Hz, 2H), 2.61 (t,J = 6.3 Hz, 2H), 2.33–0.72 (m,
92H); 13C NMR (100 MHz, CDCl3) δ 193.4, 172.9,
172.7, 172.1, 169.4, 168.0, 77.4, 75.5, 55.3, 53.3,
50.2, 49.1, 48.0, 47.5, 46.8, 45.9, 45.2, 41.8, 41.7,
39.2, 35.7, 35.1, 34.8, 34.1, 32.1, 31.81, 31.77, 31.52,
31.46, 30.1, 29.41, 29.36, 29.25, 29.23, 29.20, 28.9,
27.8, 27.7, 27.4, 27.1, 27.0, 26.9, 26.53, 26.50, 25.9,
25.5, 23.5, 23.0, 22.6, 20.2, 20.1, 17.8, 14.1, 12.7,
12.3, 11.5; IR (CH2Cl2) νmax 3323, 2958, 2927, 2865,
1745, 1729, 1636, 1466, 1419, 1272, 1202, 1144
cm−1; MS (FAB) m/e 1074 (M+), 581 (M+-C40H71NO).
3α - [[[[4- (Diphenylamino)-1,4-dioxobutyl]ami-
no] acetyl] oxy] - 12α-[[[[(diethylamino)thioxomethyl]
thio] - acetyl]oxy] - N,N - dioctyl-5β-cholan-24-amide
(12c). Waxy solid; TLC (silica gel, 10%
acetone/CH2Cl2) Rf 0.40; 1H NMR (400 MHz,
CDCl3) δ 7.31 (br s, 10H), 6.51 (t, J = 5.2 Hz, 1H),
5.13 (br s, 1H, 12β-H), 4.81–4.73 (m, 1H, 3β-H),
4.39 (d, J = 16.5 Hz, 1H), 4.22 (d, J = 16.5 Hz, 1H),
4.03–3.93 (m, 4H), 3.81–3.79 (m, 2H), 3.35–3.18 (m,
4H), 2.59 (s, 4H), 2.36–0.72 (m, 85H); 13C NMR (100
MHz, CDCl3) δ 193.3, 172.8, 172.3, 172.0, 169.3,
167.9, 142.5, 129.7, 128.8, 127.9, 126.4, 77.2, 75.5,
60.3, 50.1, 49.0, 47.9, 47.4, 46.8, 45.8, 45.1, 41.8,
39.1, 35.6, 35.0, 34.7, 34.2, 34.0, 32.0, 31.73, 31.70,
31.4, 31.2, 31.0, 30.0, 29.33, 29.28, 29.18, 29.15,
29.13, 27.7, 27.34, 27.0, 26.9, 26.8, 26.5, 25.8, 25.4,
23.4, 22.9, 22.6, 17.7, 14.1, 14.0, 12.6, 12.2, 11.5;
IR (CH2Cl2) νmax 3445, 3065, 2931, 2857, 2083,
1722, 1670, 1644, 1488, 1419, 1377, 1358, 1265,
1203, 756, 702 cm−1; MS (FAB) m/e 1114 (M+), 581
(M+-C40H71NO).
3α-[[[[4-(Diethylamino)-1,4-dioxobutyl]amino]
acetyl] oxy] - 12α - [[[[(diethylamino) thioxomethyl]
thio]-acetyl]oxy]-5β-cholane (13a). Waxy solid; TLC
1
(silica gel, 20% acetone/CH2Cl2) Rf 0.44; H NMR
(400 MHz, CDCl3) δ 6.78 (t, J = 5.2 Hz, 1H), 5.13 (br
s, 1H, 12β-H), 4.81–4.73 (m, 1H, 3β-H), 4.39 (d, J =
16.4 Hz, 1H), 4.21 (d, J = 16.4 Hz, 1H), 4.06–3.94 (m,
4H), 3.81 (m, 2H), 3.40–3.30 (m, 4H), 2.69–2.59 (m,
4H), 1.97–0.71 (m, 56H); 13C NMR (100 MHz, CDCl3)
δ 193.5, 172.7, 170.8, 169.4, 168.0, 77.4, 75.5, 50.2,
49.1, 47.6, 46.8, 45.1, 41.89, 41.86, 41.7, 40.4, 38.1,
35.7, 35.1, 34.8, 34.3, 34.1, 32.1, 31.3, 28.5, 27.5, 26.9,
26.5, 25.9, 25.5, 23.5, 23.0, 19.2, 17.8, 14.6, 14.1, 13.1,
12.7, 12.2, 11.5; IR (CH2Cl2) νmax 3379, 2955, 2936,
2872, 1741, 1673, 1626, 1543, 1487, 1420, 1270, 1203
cm−1; HRMS calcd. for C41H69N3O6S2 m/e 763.4628,
found 763.4627.
3α-[[[[4-(Diisobytylamino)-1,4-dioxobutyl]ami-
no]acetyl]oxy]-12α -[[[[(diethylamino)thioxomethyl]
thio]-acetyl]oxy]-5β-cholane (13b). Waxy solid; TLC
1
(silica gel, 15% acetone/CH2Cl2) Rf 0.53; H NMR
(400 MHz, CDCl3) δ 6.62 (t, J = 5.0 Hz, 1H), 5.13
(br s, 1H, 12β-H), 4.80–4.72 (m, 1H, 3β-H), 4.39 (d,
J = 16.4 Hz, 1H), 4.21 (d, J = 16.4 Hz, 1H), 4.07–
3.94 (m, 4H), 3.81 (m, 2H), 3.19 (d, 2H), 3.11 (d,
2H), 2.70 (t, 2H), 2.60 (t, 2H), 2.05–0.71 (m, 64H);
13C NMR (100 MHz, CDCl3) δ 193.5, 172.7, 172.0,
169.4, 168.0, 77.5, 75.6, 55.3, 53.3, 50.2, 49.1, 47.6,
46.8, 45.1, 41.9, 41.7, 39.3, 38.1, 35.7, 35.1, 34.8, 34.3,
34.1, 32.1, 31.6, 29.0, 27.7, 27.5, 26.9, 26.53, 26.51,
25.9, 25.5, 23.5, 23.0, 20.2, 20.1, 19.2, 17.8, 14.6,
12.7, 12.2, 11.5; IR (CH2Cl2) νmax 3322, 2961, 2931,
2871, 1744, 1676, 1638, 1544, 1420, 1269, 1203, 1146
cm−1; HRMS calcd. for C45H77N3O6S2 m/e 819.5254,
found 819.5253.
General Procedure for the Preparation of
3α-[[[[4-(Di(alkyl, aryl)amino)-1,4-dioxobutyl]ami-
no]acetyl]oxy]- 12α-[[[[(diethylamino)thioxomethyl]
thio]acetyl]oxy]-5β-cholanes 13a, 13b, and 13c.
N, N-Di(alkyl, aryl)carbamoylpropanoic acid (1.78
mmol) and HOBt (240 mg, 1.78 mmol) were dis-
solved in dichloromethane (10 mL), DMF (1 mL)
at room temperature and stirred for 10 min. EDC
(340 mg, 1.78 mmol) was added to the reaction mix-
ture and stirred for 30 min. 3α-Aminoacetoxy-12α-
3α -[[[[4-(Diphenylamino)-1,4-dioxobutyl]ami-
no]acetyl]oxy]-12α-[[[[(diethylamino)thioxomethyl]
thio]-acetyl]oxy]-5β-cholane (13c). Waxy solid; TLC
1
(silica gel, 10% acetone/CH2Cl2) Rf 0.45; H NMR
(400 MHz, CDCl3) δ 7.28 (br s, 10H), 6.55 (t, J = 5.1
Hz, 1H), 5.11 (br s, 1H, 12β-H), 4.78–4.71 (m, 1H, 3β-
H), 4.38 (d, J = 16.3 Hz, 1H), 4.19 (d, J = 16.3 Hz,
1H), 4.04–3.94 (m, 4H), 3.77 (m, 2H), 2.57 (s, 4H),
Heteroatom Chemistry DOI 10.1002/hc